Pharmacom Biovet Valuation
| PHMB Stock | USD 0.0001 0.00 0.00% |
Pharmacom Biovet seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Pharmacom Biovet from analyzing the company fundamentals such as Working Capital of (29 K), current valuation of 1.08 M, and Beta of 168.8 as well as examining its technical indicators and probability of bankruptcy.
Enterprise Value 1.1 M |
Overvalued
Today
Please note that Pharmacom Biovet's price fluctuation is very steady at this time. Calculation of the real value of Pharmacom Biovet is based on 3 months time horizon. Increasing Pharmacom Biovet's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Pharmacom Biovet is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharmacom Stock. However, Pharmacom Biovet's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The real value of Pharmacom Stock, also known as its intrinsic value, is the underlying worth of Pharmacom Biovet Company, which is reflected in its stock price. It is based on Pharmacom Biovet's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pharmacom Biovet's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pharmacom Biovet helps investors to forecast how Pharmacom stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharmacom Biovet more accurately as focusing exclusively on Pharmacom Biovet's fundamentals will not take into account other important factors: Pharmacom Biovet Total Value Analysis
Pharmacom Biovet is at this time expected to have valuation of 1.08 M with market capitalization of 1.08 M, debt of 61.54 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pharmacom Biovet fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.08 M | 1.08 M | 61.54 K |
Pharmacom Biovet Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Pharmacom suggests not a very effective usage of assets in January.Pharmacom Biovet Profitability Analysis
Net Loss for the year was (556.18 K) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pharmacom Biovet's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pharmacom Biovet and how it compares across the competition.
About Pharmacom Biovet Valuation
The stock valuation mechanism determines Pharmacom Biovet's current worth on a weekly basis. Our valuation model uses a comparative analysis of Pharmacom Biovet. We calculate exposure to Pharmacom Biovet's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharmacom Biovet's related companies.Complementary Tools for Pharmacom Stock analysis
When running Pharmacom Biovet's price analysis, check to measure Pharmacom Biovet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacom Biovet is operating at the current time. Most of Pharmacom Biovet's value examination focuses on studying past and present price action to predict the probability of Pharmacom Biovet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacom Biovet's price. Additionally, you may evaluate how the addition of Pharmacom Biovet to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |